Resveratrol Restores Intracellular Transport in Cystic Fibrosis Epithelial Cells

Overview

Journal Am J Physiol Lung Cell Mol Physiol

Publisher American Physiological Society

Specialties Cell Biology
Molecular Biology
Physiology
Pulmonary Medicine

Date 2020 Apr 9

PMID 32267731

Citations 9

Authors

Binyu Lu

Deborah A Corey

Thomas J Kelley

Affiliations

Soon will be listed here.

Abstract

We have demonstrated previously that intracellular transport is impaired in cystic fibrosis (CF) epithelial cells. This impairment is related to both growth and inflammatory regulation in CF cell and animal models. Understanding how transport in CF cells is regulated and identifying means to manipulate that regulation are key to identifying new therapies that can address key CF phenotypes. It was hypothesized that resveratrol could replicate these benefits since it interfaces with multiple pathways identified to affect microtubule regulation in CF. It was found that resveratrol treatment significantly restored intracellular transport as determined by monitoring both cholesterol distribution and the distribution of rab7-positive organelles in CF cells. This restoration of intracellular transport is due to correction of both microtubule formation rates and microtubule acetylation in cultured CF cell models and primary nasal epithelial cells. Mechanistically, the effect of resveratrol on microtubule regulation and intracellular transport was dependent on peroxisome proliferator-activated receptor-γ signaling and its ability to act as a pan-histone deacetylase (HDAC) inhibitor. Resveratrol represents a candidate compound with known anti-inflammatory properties that can restore both microtubule formation and acetylation in CF epithelial cells.

Citing Articles

In vivo impact of tubulin polymerization promoting protein (Tppp) knockout to the airway inflammatory response.

Endres T, Duesler L, Corey D, Kelley T Sci Rep. 2023; 13(1):12272.

PMID: 37507487 PMC: 10382518. DOI: 10.1038/s41598-023-39443-5.

HDAC-an important target for improving tumor radiotherapy resistance.

Ling R, Wang J, Fang Y, Yu Y, Su Y, Sun W Front Oncol. 2023; 13:1193637.

PMID: 37503317 PMC: 10368992. DOI: 10.3389/fonc.2023.1193637.

Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 Patients.

Zhou Y, Gallins P, Pace R, Dang H, Aksit M, Blue E Am J Respir Crit Care Med. 2023; 207(10):1324-1333.

PMID: 36921087 PMC: 10595435. DOI: 10.1164/rccm.202209-1653OC.

Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?.

Trandafir L, Frasinariu O, Tarca E, Butnariu L, Leon Constantin M, Moscalu M Nutrients. 2023; 15(2).

PMID: 36678185 PMC: 9860597. DOI: 10.3390/nu15020314.

Improving Lipophagy by Restoring Rab7 Cycle: Protective Effects of Quercetin on Ethanol-Induced Liver Steatosis.

Lin H, Guo X, Liu J, Liu P, Mei G, Li H Nutrients. 2022; 14(3).

PMID: 35277017 PMC: 8915175. DOI: 10.3390/nu14030658.

References

Kelly-Aubert M, Trudel S, Fritsch J, Nguyen-Khoa T, Baudouin-Legros M, Moriceau S . GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models. Hum Mol Genet. 2011; 20(14):2745-59. DOI: 10.1093/hmg/ddr173. View

Rymut S, Ivy T, Corey D, Cotton C, Burgess J, Kelley T . Role of Exchange Protein Activated by cAMP 1 in Regulating Rates of Microtubule Formation in Cystic Fibrosis Epithelial Cells. Am J Respir Cell Mol Biol. 2015; 53(6):853-62. PMC: 4742938. DOI: 10.1165/rcmb.2014-0462OC. View

Shen Y, Chen L, Wang T, Wen F . PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases. PPAR Res. 2012; 2012:256874. PMC: 3385647. DOI: 10.1155/2012/256874. View

Konstan M, Schluchter M, Xue W, Davis P . Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis. Am J Respir Crit Care Med. 2007; 176(11):1084-9. PMC: 2176097. DOI: 10.1164/rccm.200702-181OC. View

Sehrawat S, Cullere X, Patel S, Italiano Jr J, Mayadas T . Role of Epac1, an exchange factor for Rap GTPases, in endothelial microtubule dynamics and barrier function. Mol Biol Cell. 2008; 19(3):1261-70. PMC: 2262967. DOI: 10.1091/mbc.e06-10-0972. View

Manson M, Corey D, White N, Kelley T . cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells. Am J Physiol Lung Cell Mol Physiol. 2008; 295(5):L809-19. PMC: 2584893. DOI: 10.1152/ajplung.90402.2008. View

Harkcom W, Ghosh A, Sung M, Matov A, Brown K, Giannakakou P . NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents. Proc Natl Acad Sci U S A. 2014; 111(24):E2443-52. PMC: 4066477. DOI: 10.1073/pnas.1404269111. View

Rymut S, Kampman C, Corey D, Endres T, Cotton C, Kelley T . Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2016; 311(2):L317-27. PMC: 5142453. DOI: 10.1152/ajplung.00126.2016. View

Wang G, Chen L, Pan X, Chen J, Wang L, Wang W . The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling. Oncotarget. 2016; 7(14):17380-92. PMC: 4951219. DOI: 10.18632/oncotarget.8041. View

10.

Sadeghi A, Seyyed Ebrahimi S, Golestani A, Meshkani R . Resveratrol Ameliorates Palmitate-Induced Inflammation in Skeletal Muscle Cells by Attenuating Oxidative Stress and JNK/NF-κB Pathway in a SIRT1-Independent Mechanism. J Cell Biochem. 2017; 118(9):2654-2663. DOI: 10.1002/jcb.25868. View

11.

Lands L, Milner R, Cantin A, Manson D, Corey M . High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial. J Pediatr. 2007; 151(3):249-54. DOI: 10.1016/j.jpeds.2007.04.009. View

12.

Harmon G, Dumlao D, Ng D, Barrett K, Dennis E, Dong H . Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice. Nat Med. 2010; 16(3):313-8. PMC: 2834836. DOI: 10.1038/nm.2101. View

13.

Cho D, Zhang S, Lazrak A, Grayson J, Garcia J, Skinner D . Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease. Int Forum Allergy Rhinol. 2018; 9(1):100-105. PMC: 6318032. DOI: 10.1002/alr.22202. View

14.

Valdivieso A, Clauzure M, Marin M, Taminelli G, Massip Copiz M, Sanchez F . The mitochondrial complex I activity is reduced in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function. PLoS One. 2012; 7(11):e48059. PMC: 3504030. DOI: 10.1371/journal.pone.0048059. View

15.

Kreiselmeier N, Kraynack N, Corey D, Kelley T . Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2003; 285(6):L1286-95. DOI: 10.1152/ajplung.00127.2003. View

16.

Thomas E, Gopalakrishnan V, Hegde M, Kumar S, Karki S, Raghavan S . A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells. Sci Rep. 2016; 6:34653. PMC: 5066224. DOI: 10.1038/srep34653. View

17.

Rymut S, Harker A, Corey D, Burgess J, Sun H, Clancy J . Reduced microtubule acetylation in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2013; 305(6):L419-31. PMC: 3763039. DOI: 10.1152/ajplung.00411.2012. View

18.

Rouse M, Younes A, Egan J . Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity. J Endocrinol. 2014; 223(2):107-17. PMC: 4191183. DOI: 10.1530/JOE-14-0335. View

19.

Aires V, Brassart B, Carlier A, Scagliarini A, Mandard S, Limagne E . A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis. Mol Nutr Food Res. 2014; 58(9):1785-94. DOI: 10.1002/mnfr.201300962. View

20.

Lee J, Elmer H, Ross K, Kelley T . Isoprenoid-mediated control of SMAD3 expression in a cultured model of cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol. 2004; 31(2):234-40. DOI: 10.1165/rcmb.2003-0447OC. View